Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.

Spohn G, Jennings GT, Martina BE, Keller I, Beck M, Pumpens P, Osterhaus AD, Bachmann MF.

Virol J. 2010 Jul 6;7:146. doi: 10.1186/1743-422X-7-146.

2.

Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.

Throsby M, Ter Meulen J, Geuijen C, Goudsmit J, de Kruif J.

Expert Rev Vaccines. 2007 Apr;6(2):183-91. Review.

PMID:
17408368
3.

Plant-made vaccines against West Nile virus are potent, safe, and economically feasible.

Chen Q.

Biotechnol J. 2015 May;10(5):671-80. doi: 10.1002/biot.201400428. Epub 2015 Feb 9. Review.

4.

The molecular basis of antibody protection against West Nile virus.

Mehlhop E, Diamond MS.

Curr Top Microbiol Immunol. 2008;317:125-53. Review.

PMID:
17990792
5.

Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus.

Dayan GH, Pugachev K, Bevilacqua J, Lang J, Monath TP.

Viruses. 2013 Dec 9;5(12):3048-70. doi: 10.3390/v5123048. Review.

6.

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.

Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4. Review.

PMID:
19808029
7.

The molecular basis of antibody-mediated neutralization of West Nile virus.

Oliphant T, Diamond MS.

Expert Opin Biol Ther. 2007 Jun;7(6):885-92. Review.

PMID:
17555373
8.

Vaccines in development against West Nile virus.

Brandler S, Tangy F.

Viruses. 2013 Sep 30;5(10):2384-409. doi: 10.3390/v5102384. Review.

9.

ChimeriVax-West Nile vaccine.

Hall RA, Khromykh AA.

Curr Opin Mol Ther. 2007 Oct;9(5):498-504. Review.

PMID:
17932814
10.

Prospects for development of a vaccine against the West Nile virus.

Monath TP.

Ann N Y Acad Sci. 2001 Dec;951:1-12. Review.

PMID:
11797767
11.

West Nile Virus: is a vaccine needed?

Martina BE, Koraka P, Osterhaus AD.

Curr Opin Investig Drugs. 2010 Feb;11(2):139-46. Review.

PMID:
20112163
12.

West Nile virus: recent trends in diagnosis and vaccine development.

Dauphin G, Zientara S.

Vaccine. 2007 Jul 26;25(30):5563-76. Epub 2006 Dec 22. Review.

PMID:
17292514
13.

Technologies for the development of West Nile virus vaccines.

Ulbert S, Magnusson SE.

Future Microbiol. 2014;9(10):1221-32. doi: 10.2217/fmb.14.67. Review.

14.

Current trends in West Nile virus vaccine development.

Amanna IJ, Slifka MK.

Expert Rev Vaccines. 2014 May;13(5):589-608. doi: 10.1586/14760584.2014.906309. Epub 2014 Apr 1. Review.

15.

The structural immunology of antibody protection against West Nile virus.

Diamond MS, Pierson TC, Fremont DH.

Immunol Rev. 2008 Oct;225:212-25. doi: 10.1111/j.1600-065X.2008.00676.x. Review.

16.

Current developments in understanding of West Nile virus central nervous system disease.

Tyler KL.

Curr Opin Neurol. 2014 Jun;27(3):342-8. doi: 10.1097/WCO.0000000000000088. Review.

17.

Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

Beasley DW.

Immunotherapy. 2011 Feb;3(2):269-85. doi: 10.2217/imt.10.93. Review.

PMID:
21322763
18.

Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.

Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M.

Viral Immunol. 2003;16(3):259-78. Review.

PMID:
14583143
19.

Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector.

Tangy F, Naim HY.

Viral Immunol. 2005;18(2):317-26. Review.

PMID:
16035943
20.

The innate immune playbook for restricting West Nile virus infection.

Quicke KM, Suthar MS.

Viruses. 2013 Oct 30;5(11):2643-58. doi: 10.3390/v5112643. Review.

Items per page

Supplemental Content

Write to the Help Desk